Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-20

Clinical Trial Update: Omega-3 Fatty Acid Supplements and Dry Eye [NA]

View source ↗

Summary

This clinical trial update indicates that the study evaluating omega-3 fatty acid supplements for keratoconjunctivitis sicca (dry eye) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 Fatty Acid Supplements (Omega-3 fatty acids)

Snippet

Sponsor: Ohio State University | Conditions: Keratoconjunctivitis Sicca | NA | Status: TERMINATED